Monitoring Antioxidant/Redox Status at Concordia (MARS-C)
MARS-C
1 other identifier
observational
30
1 country
1
Brief Summary
The European Space Agency (ESA) runs a research centre in Antarctica as an earth-based model for long duration deep-space missions. Just like astronauts travelling into space, crew-members overwintering at this Concordia base are exposed to a number of extreme environmental stressors; including high altitude (approximately 3800m); extreme cold; long periods of 24 hour darkness or daylight; and complete isolation. The investigators will recruit up to 30 over-wintering crew members working at this station for ESA over a 2 year period and observe how their bodies adapt and respond to the stress of living and working in this environment. The investigators will collect blood, saliva and urine samples, together with ultrasound images of muscle mass and grip strength measurements at regular intervals throughout their deployment to Antarctica. These samples will be transported back to Southampton to be analysed for biochemical levels of stress. During the final month of their stay, all participants will be randomised to receive a daily nutritional drink which is either high or low in targeted dietary supplements. Following similar studies that the investigators has successfully performed over shorter durations at high altitudes previously, they hypothesise that levels of stress experienced in extreme environments such as Antarctica or deep space can be reduced with targeted nutritional supplementation. These findings may become important to members of the general public as commercial aviation moves increasingly towards using low space-orbital vehicles to drastically reduce international travel times over the coming decade.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Oct 2022
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 4, 2019
CompletedFirst Posted
Study publicly available on registry
December 13, 2019
CompletedStudy Start
First participant enrolled
October 3, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2024
CompletedJanuary 11, 2024
January 1, 2024
2.2 years
December 4, 2019
January 9, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Hand grip strength
Forearm muscle / grip strength recorded non-invasively using a hand grip dynamometer
up to 10 months
Secondary Outcomes (3)
Muscle mass
up to 10 months
Oxidative stress
up to 10 months
Lake Louise Score 2018
up to 10 months
Eligibility Criteria
Over-wintering members of Concordia crew
You may qualify if:
- Adult
- Member of Concordia station over-wintering crew
- Able to give written informed consent
- Fluent in either English, French or Italian
You may not qualify if:
- Participating in another interventional research study during the deployment to Concordia
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Southamptonlead
- European Space Agencycollaborator
Study Sites (1)
University of Southampton
Southampton, SO16 6YD, United Kingdom
Study Officials
- PRINCIPAL INVESTIGATOR
Martin Feelisch, PhD
University of Southampton
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 4, 2019
First Posted
December 13, 2019
Study Start
October 3, 2022
Primary Completion
December 1, 2024
Study Completion
December 1, 2024
Last Updated
January 11, 2024
Record last verified: 2024-01